NCT03009916View on ClinicalTrials.gov

Bileacid Malabsorption and GLP-1 Secretion

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 3, 2017

Study Completion Date

August 4, 2017

Conditions
Bileacid Malabsorption
Interventions
DRUG

"cholestagel® (Colesevelam)"

3750mg

DRUG

Placebos

3750mg

Trial Locations (1)

2900

Center for Diabetes Research, Gentofte Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT03009916 - Bileacid Malabsorption and GLP-1 Secretion | Biotech Hunter | Biotech Hunter